Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
1,044 total articles
Remitly shares trade at roughly $17 and a low forward earnings multiple relative to growth targets; Q4 results and guidance clarity create a tactical buy opportunity. This note lays out an entry at $17.03, a stop at $14.75 and a mid-term target of $23.00 with a clear risk framework tied to volume, product adoption and credit trends.
Uber’s core platform — Mobility, Delivery, Freight — is showing profitable scale, positive free cash flow, and structural advantages that the market is underpricing. At roughly $158.3B market cap, the stock trades at mid-teens P/E with a healthy cash flow profile. This trade idea lays out a disciplined long entry at $74.00, a $100.00 target over 18…
Nano Labs (NA) has pivoted hard into crypto reserves and BNB-related infrastructure while slashing operating costs and stabilizing losses. At a market cap of roughly $76M and a current price near $3.21, the stock offers an asymmetric return profile for disciplined traders who accept high volatility, low liquidity and regulatory uncertainty. This tr…
Meta is investing aggressively in infrastructure and data-quality guardrails that make its advertising and AI personalization increasingly defensible. With a market cap around $1.66T, healthy free cash flow and improving AI partnerships, the risk/reward favors a long position over the next 180 trading days, provided you respect valuation and set a …
American Tower looks poised to re-rate as its CoreSite data center business captures AI-driven colocation demand and the stock shows improving technicals. The company offers a 3.6% yield and FCF of roughly $3.7B, supporting a tactical long trade sized for a long-term (180 trading days) horizon. Entry $185.025, stop $170.00, target $215.00.
Arcutis has doubled in a year on accelerating ZORYVE sales and encouraging guidance. Revenue upside is in the numbers — 2026 net product sales guidance of $455-470M implies rapid compounding, but valuation (EV/sales ~11x) already prices a lot of the story. This trade targets further multiple expansion into secular adoption while protecting capital …
Amazon (AMZN) looks great in headlines: top of the Fortune 500 and AWS still dominant. But under the hood the stock is priced for near-perfection, free cash flow recently turned negative, and technical momentum is failing. This actionable short trade targets a retreat toward the $170 area over the next 45 trading days with a $220 stop.
Viatris (VTRS) looks attractively priced today with a market cap near $18.7B, roughly $1.65B in annual free cash flow, and valuation multiples that sit below what you'd expect for a global pharmaceuticals player. Combine that with favorable policy headlines for generics and multiple end-market growth tailwinds, and there is a defendable long trade …
Main Street Capital (MAIN) is trading at about 1.77x book with a ~5.25% trailing dividend yield and a sub-10x P/E. Recent price weakness has pushed technicals into oversold territory and created a tactical long entry for investors who want monthly income plus modest capital appreciation. This trade plan defines a clear entry, stop and target while …
Charles Schwab looks like a buy here around $93.87. The franchise is producing strong revenue and FCF growth, client assets are at record levels, and the stock trades below its short-term moving averages with RSI near 37. Our trade plan: enter at $93.87, stop $86.00, target $110.00 over a 180-trading-day horizon.
Corcept (CORT) plunged after a 12/31/2025 FDA Complete Response Letter for relacorilant tied to hypercortisolism. That sell-off priced in a lot of regulatory and litigation downside; meanwhile relacorilant's oncology potential, especially in platinum-resistant ovarian cancer, remains underappreciated. This trade idea lays out a tactical long with c…
Texas Pacific Land (TPL) is trading with clear momentum after an energy-led rally. The business earns recurring royalties, land-use fees and growing water services revenue in the Permian Basin. Valuation is rich, but a short-term momentum trade with strict risk controls is attractive: entry $487.00, stop $435.00, target $600.00 over a mid-term (45 …
Blue Owl (OWL) has been hammered by redemptions, lawsuits and distribution uncertainty. The stock trades near its 52-week low with RSI around 30, heavy short interest and an attractive headline yield. We think the worst of headline-driven selling is largely priced in and propose a defined-risk long targeting a recovery to the mid-teens over a 180-t…
Huntsman (HUN) trades at a sub-1x price-to-book and roughly 0.4x price-to-sales while producing meaningful free cash flow. A $0.0875/share dividend and secular demand tailwinds in polyurethanes, TPU and amines create a favorable entry for patient investors. This trade idea lays out an entry, stop and target across time horizons and highlights the o…
Planet Labs operates the largest commercial Earth-imaging fleet and is converting that coverage into recurring analytics revenue. At $25.27 today, the stock already reflects a big rerating; this idea is a long-term trade that banks on continued government deals, backlog monetization and improving unit economics. Use strict risk controls—stop at $18…
Constellation Energy (CEG) is evolving from a traditional utility into a critical infrastructure provider for AI-scale compute. The company’s carbon-free nuclear fleet, recent large acquisitions and long-term PPAs with hyperscalers create an earnings profile that can re-rate as AI data-center electrification becomes a structural demand story. We la…
TTM Technologies (TTMI) is trading at roughly $100.75 after a strong run driven by AI/data-center exposure and a recent S&P MidCap promotion. With roughly 36% of sales tied to data-center computing and AI, management forecasting 15-20% sales growth for 2026, and a healthier balance sheet (debt/equity ~0.52), this is a tactical long for investors wh…
SAP fell sharply in recent sessions as software names sold off, leaving the stock nearer its 52-week low. Fundamentals remain solid: $246.6B market cap, recurring cloud revenue, and strategic AI-cloud tie-ups. Technicals show oversold conditions and nascent bullish MACD momentum. This is a tactical buying opportunity for a mid-term swing (45 tradin…
Broadcom (AVGO) looks attractively positioned after a recent pullback driven by headline AI CapEx concerns. The company combines high-margin custom silicon, networking gear and sticky infrastructure software, generating $26.9B in free cash flow and a fortress-like ROE of ~28%. With the stock trading near $333.93 and rich multiples priced for perfec…
Interactive Brokers (IBKR) is a capital-efficient, electronically native brokerage that continues to compound earnings via account growth, margin expansion and outsized free cash flow. Trade plan: enter at $74.00, stop $66.00, target $98.00 over a long-term horizon (180 trading days).
Fortress Biotech (FBIO) is a $108M microcap with improving fundamentals, recent non-core asset monetization and enough cash to survive execution risk. The market's focal point is a possible Priority Review Voucher (PRV) pathway tied to legacy assets and recent regulatory developments. If management captures or monetizes a PRV, the stock can reprice…
Wendy's plunged on execution worries and a messy reset, but the business still throws off meaningful free cash flow (FCF $237.8M) and trades at single-digit earnings multiples (P/E ~9.6, EV/EBITDA ~8.5). With activist Trian pushing for value-creating options and the stock sitting near its 52-week low ($6.73), the risk/reward favors a long trade her…
eBay's acquisition of Depop, stronger-than-expected Q4 results and a $2B buyback authorization make the stock attractive around $85. The business is producing solid free cash flow ($1.53B), GMV is expanding ($21.2B), and management is targeting younger buyers via Depop - a catalyst that should re-rate the multiple. My swing trade: buy $85, stop $78…
Provident Financial Services (PFS) has already rallied from its 52-week low to trade near $23, but earnings, a 4%+ yield, and a fresh buyback authorization give the stock a concrete path to further gains. This trade idea lays out an entry at $22.95, a stop at $21.00 and a target at $27.50 for a mid-term push over roughly 45 trading days.
Sunoco L.P. is positioned to grow its distribution at least 5% in 2026 backed by $600M+ growth capex and $3.1-$3.3B adjusted EBITDA guidance. Valuation is reasonable with a $9.81B market cap, $17.79B enterprise value and an EV/EBITDA of ~11.1. I recommend a long trade to capture distribution and re-rating potential, with tight risk controls to navi…
